[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 22, 1992

Regulation of Benzodiazepine Prescription-Reply

Author Affiliations

Deputy Editor, JAMA

JAMA. 1992;268(4):474. doi:10.1001/jama.1992.03490040048021

In Reply.  —I appreciate the interest of Drs Wolfe, Lurie, and Kahn and Mr Levin in my Editorial. However, the charge that it represented "AMA bias" is unwarranted. As Dr Wolfe knows, JAMA is editorially independent from the AMA. The views I expressed were based on my appraisal of the relevant scientific literature, including the study by Weintraub et al,1 and my clinical experience as a psychiatrist. I cited AMA policy to inform readers about it, and I also cited some positive views of the regulations.2,3Mr Levin states that "there is no difference in the physician or patient experience" with the triplicate forms. Drs Wolfe and Lurie quote a similar assertion that there is no restriction of medical judgment, since physicians "simply write the prescription on a different form." These statements are at odds with reports of the reactions of patients and physicians to the New York